nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

08.05.2020 | Letter to the Editor

[⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

verfasst von: Jieling Zheng, Shaobo Yao

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Chen HJ, Pang YZ, Wu JX, Zhao L, Hao B, Wu J, et al. Comparison of [⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020. https://link.springer.com/article/10.1007/s00259-020-04769-z. Accessed 30 Mar 2020.

Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, et al. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases. 2019;7(14):1732–52.CrossRef

Glasbrenner B, Ardan M, Boeck W, Preclik G, Möller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy. 1999;31(9):712–7.CrossRef

Jailwala J, Fogel EL, Sherman S, Gottlieb K, Flueckiger J, Bucksot LG, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc. 2000;51:383–90.CrossRef

Nishiyama Y, Yamamoto Y, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, et al. Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nucl Med Commun. 2007;28(12):914–9.CrossRef

Lewis HL, Rahnemai-Azar AA, Dillhoff M, Schmidt CR, Pawlik TM. Current management of perihilar cholangiocarcinoma and future perspectives. Chirurgia (Bucur). 2017;112(3):193–207.

Luo YP, Pan QQ, Zhang W. IgG4-related disease revealed by ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2019;46(12):2625–6.

Luo YP, Pan QQ, Zhang W, Li F. Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in ⁶⁸Ga-FAPI PET/CT. Clin Nucl Med. 2020;45(4):310–1.CrossRef

Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. ⁶⁸Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801–5.CrossRef

10.

Choi EK, Yoo IR, Kim SH, JH O, Choi WH, Na SJ, et al. The clinical value of dual-time point ¹⁸F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease. Clin Nucl Med. 2013;38(3):106–11.CrossRef

Titel: [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer
verfasst von: Jieling Zheng
Shaobo Yao
Publikationsdatum: 08.05.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-020-04847-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2020

Deep learning-based interpretation of basal/acetazolamide brain perfusion SPECT leveraging unstructured reading reports

Radionuclide therapy in the time of COVID-19

Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis

Slice-selective learning for Alzheimer’s disease classification using a generative adversarial network: a feasibility study of external validation

Correction to: Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography-based radiomics and genetic alterations of pancreatic ductal adenocarcinoma

Does gallium-citrate have yet another story to tell? Lessons relevant to the COVID-19 era